MED (Medifast) E10: $6.93 (As of Mar. 2026)


MED Medifast Inc MED
69 GF Score
Price $10.36
GF Value $8.75
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast E10?

Medifast MED -2.45% 69 E10 is $6.93 as of Mar. 2026. GuruFocus rates MED with a GF Score™ of 69/100 and a GF Value™ of $8.75 (Modestly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medifast's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $6.93 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medifast's average E10 Growth Rate was -2.50% per year. During the past 3 years, the average E10 Growth Rate was 4.00% per year. During the past 5 years, the average E10 Growth Rate was 16.20% per year. During the past 10 years, the average E10 Growth Rate was 25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Medifast was 36.60% per year. The lowest was 4.00% per year. And the median was 21.30% per year.

As of today (2026-06-25), Medifast's current stock price is $10.36. Medifast's E10 for the quarter that ended in Mar. 2026 was $6.93. Medifast's Shiller PE Ratio of today is 1.49.

During the past 13 years, the highest Shiller PE Ratio of Medifast was 154.65. The lowest was 1.40. And the median was 35.41.


Medifast  (NYSE:MED) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medifast's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=10.36/6.93
=1.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Medifast was 154.65. The lowest was 1.40. And the median was 35.41.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medifast E10 Related Terms


Medifast E10 Historical Data

* Premium members only.

The historical data trend for Medifast's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast E10 Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.66 6.10 6.99 7.07 6.87

Medifast Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.11 7.13 7.09 6.87 6.93

MED vs RGS, VGES, EVTK: E10 Comparison

For the Personal Services subindustry, Medifast's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Shiller PE Ratio vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's Shiller PE Ratio falls into.


MED
69GF Score
Medifast Inc MED
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medifast's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.19/330.2130*330.2130
=-0.190

Current CPI (Mar. 2026) = 330.2130.

Medifast Quarterly Data

per share eps CPI Adj_EPS
201606 0.290 241.018 0.397
201609 0.510 241.428 0.698
201612 0.340 241.432 0.465
201703 0.510 243.801 0.691
201706 0.630 244.955 0.849
201709 0.550 246.819 0.736
201712 0.600 246.524 0.804
201803 1.010 249.554 1.336
201806 1.160 251.989 1.520
201809 1.140 252.439 1.491
201812 1.300 251.233 1.709
201903 1.700 254.202 2.208
201906 1.750 256.143 2.256
201909 1.320 256.759 1.698
201912 1.660 256.974 2.133
202003 1.560 258.115 1.996
202006 1.860 257.797 2.382
202009 2.910 260.280 3.692
202012 2.360 260.474 2.992
202103 3.460 264.877 4.313
202106 3.960 271.696 4.813
202109 3.560 274.310 4.286
202112 2.910 278.802 3.447
202203 3.590 287.504 4.123
202206 3.420 296.311 3.811
202209 3.270 296.808 3.638
202212 2.430 296.797 2.704
202303 3.670 301.836 4.015
202306 2.770 305.109 2.998
202309 2.120 307.789 2.274
202312 0.500 306.746 0.538
202403 0.760 312.332 0.804
202406 -0.750 314.175 -0.788
202409 0.100 315.301 0.105
202412 0.070 315.605 0.073
202503 -0.070 319.799 -0.072
202506 0.220 322.561 0.225
202509 -0.210 324.800 -0.213
202512 -1.650 324.054 -1.681
202603 -0.190 330.213 -0.190

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $6.93 mean?
Medifast (MED) has a E10 of $6.93 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medifast and its competitors.
Is Medifast's E10 too high?
Medifast's current E10 is $6.93. Overall, Medifast has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's E10 compare to RGS and VGES?
Medifast's E10 of $6.93 can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Personal Services company?
A good E10 depends on the Personal Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medifast and its competitors. Medifast's current E10 is $6.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (MED) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.75, compared to a current price of $10.36 — trading 18.4% above its estimated fair value. The current E10 is $6.93. Medifast's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Medifast (MED), the current E10 is $6.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of $10.36 is trading 18.4% above its estimated GF Value™ of $8.75. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for MED:

  • E10: $6.93
  • GF Value™: $8.75 vs. price of $10.36 (18.4% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges 0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score

Get the complete analysis for MED

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.36
Price
$8.75
GF Value